Trademark Overview
On Monday, April 22, 2024, a trademark application was filed for AMNIOXPRESS with the United States Patent and Trademark Office. The USPTO has given the AMNIOXPRESS trademark a serial number of 98512922. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 19, 2024. This trademark is owned by MiMedx Group, Inc.. The AMNIOXPRESS trademark is filed in the Pharmaceutical Products category with the following description:
Human biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material
